{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P62328",
      "entity_text" : "FX",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P26482",
      "entity_text" : "FIXa",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Our results indicated that emicizumab 's hemostatic activity does not include AT or TFPI inhibition and, therefore, that emicizumab exerts its hemostatic activity at the step of FIXa catalyzed FX activation via its FVIIIa cofactor function.",
  "reading_complete" : "2020-08-03T12:56:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:54:35Z",
  "trigger" : "catalyzed",
  "evidence" : [ "FIXa-catalyzed FX" ],
  "pmc_id" : "6524866",
  "score" : 0
}